Co-Diagnostics, Inc. Deferred Revenue (Non-Current)
Co-Diagnostics, Inc. (CODX) had Deferred Revenue (Non-Current) of $126.07 thousand as of 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2019-04-01
- 2018-09-30: Deferred Revenue, Noncurrent $126.07K.
- 2018-06-30: Deferred Revenue, Noncurrent $135.76K.
- 2018-03-31: Deferred Revenue, Noncurrent $145.46K.
- 2017-12-31: Deferred Revenue, Noncurrent $183.55K.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2018-09-30 | $126.07K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $135.76K 10-Q · filed 2018-08-10 |
| 2018-03-31 | $145.46K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $183.55K 10-K · filed 2019-04-01 |
| 2017-09-30 | $186.14K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $188.74K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |